Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.6K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Brief Report: Translating Selection Criteria for Lung Cancer Screening to an Indian Context-An Analysis From a Tertiary Health Centre.
JTO clinical and research reports·2026
Same author
Acquired unilateral bronchomegaly secondary to pulmonary carcinoid tumour.
Lung India : official organ of Indian Chest Society·2026
Same author
Indian Council of Medical Research's network of pulmonary fibrosis (INPF): A big step forward towards understanding interstitial lung diseases in India.
Lung India : official organ of Indian Chest Society·2026
Related Experiment Video
Updated: Jan 21, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
10.3K
TLRs in pulmonary diseases.
Shweta Arora1, Shaniya Ahmad1, Rasha Irshad1
1Department of Biotechnology, Jamia Millia Islamia, New Delhi, India.
Life Sciences
|July 24, 2019
Summary
Toll-like receptors (TLRs) are crucial for lung defense against pathogens and diseases like asthma and lung cancer. Targeting TLR signaling offers new therapeutic strategies for pulmonary disorders and cancer vaccines.
Area of Science:
- Immunology
- Pulmonology
- Molecular Biology
Background:
- Toll-like receptors (TLRs) are key proteins in the innate immune system, recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).
- The lungs, constantly exposed to environmental threats, express various TLRs on stromal and myeloid cells to initiate host defense mechanisms.
- Dysregulation of TLR signaling is implicated in various pulmonary conditions, including infections, interstitial lung disease, acute lung injury, COPD, asthma, and lung cancer.
Purpose of the Study:
- To review the multifaceted role of Toll-like receptors (TLRs) in pulmonary health and disease.
- To highlight the therapeutic potential of targeting TLR signaling pathways for treating lung diseases and enhancing cancer immunotherapy.
Main Methods:
- Literature review and synthesis of existing research on TLRs in the context of lung immunity and pathology.
- Analysis of TLRs' involvement in host defense against microbial infections and non-infectious pulmonary disorders.
- Exploration of TLRs' implications in lung cancer development and treatment strategies.
Main Results:
- TLRs are essential for recognizing PAMPs and DAMPs in the lung, initiating immune responses crucial for host defense.
- Aberrant TLR activation contributes to the pathogenesis of diverse pulmonary diseases, including inflammatory and obstructive airway diseases, and lung cancer.
- Targeting TLR signaling pathways presents promising therapeutic avenues for infectious lung diseases, allergic conditions, and as adjuvants for cancer vaccines.
Conclusions:
- Toll-like receptors play a pivotal role in lung immunity, inflammation, and disease pathogenesis.
- Modulating TLR signaling networks offers significant potential for developing novel treatments for a spectrum of pulmonary diseases and improving lung cancer immunotherapy.